CNBSF
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
CIN assigns Cansortium / Fluent a Neutral rating with a 40.8 composite score and 3/5 conviction. The regulatory pillar leads at 49, supported by an 80 enforcement subscore and a 50 jurisdiction posture, although a 25 cadence subscore limits the contribution. Fundamentals and market each contribute 40, but both reflect information gaps rather than demonstrated operating or trading strength. The fundamentals pillar carries an unknown condition because licensed fundamentals data are unavailable, while the market pillar lacks a current quote from institutional pricing feeds. Editorial contributes 30, the weakest pillar, with no newsroom or brief activity recorded in CIN newsroom coverage. The resulting profile sits firmly in the Neutral band: regulatory standing provides relative support, but absent financial, pricing, and editorial confirmation prevents a stronger rating.
Revenue growth and margin direction cannot be established from the available inputs. No revenue, gross margin, operating margin, EBITDA, net income, cash, or leverage figures are supplied through licensed fundamentals data, leaving the company’s financial condition unknown. Primary regulatory filings also provide no dated latest filing in the dataset, while filing-related event counts remain at zero across both the 90-day and 180-day windows. That absence drives the weak cadence subscore and reduces confidence in financial recency. At the same time, zero enforcement hits support the regulatory pillar’s strongest subscore. Institutional pricing feeds provide no quote, preventing assessment of momentum, valuation, liquidity, or market confirmation. CIN newsroom coverage contains no newsroom hits and no brief hits, matching the editorial pillar’s low contribution.
The clearest path to a higher composite runs through the regulatory pillar, already the strongest component of the framework. A current primary regulatory filing could lift cadence from its depressed level, establish an updated disclosure timeline, and supply the operating evidence currently missing from fundamentals. Such a filing could also clarify revenue growth, margins, and financial condition without relying on unsupported inference. With jurisdiction posture near the midpoint and enforcement history providing the strongest support, improved filing recency represents the most direct catalyst for conviction. The single most important signal to watch is the appearance of a newly dated primary regulatory filing.
- Website
- Company website
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for CNBSF (CNBSF)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for CNBSF (CNBSF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Neutral / Wait. Mixed data profile. Await clearer directional signal. (0 bullish signals, 0 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for CNBSF are maintained by Cannabis Investor News and refreshed throughout the trading day.